LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES - FIRST INTERIM ANALYSIS OF THE FMF/TRAPS/HIDS SUBGROUPS FROM THE RELIANCE REGISTRY

被引:0
|
作者
Henes, J. [1 ]
Kuemmerle-Deschner, J. B. [1 ]
Borte, M. [2 ]
Foeldvari, I.
Horneff, G. [3 ]
Kallinich, T. [4 ]
Kortus-Goetze, B. [5 ]
Weller-Heinemann, F. [6 ]
Weber-Arden, J. [7 ]
Blank, N. [8 ]
机构
[1] Univ Hosp, Tubingen, Germany
[2] Hosp St Georg, Leipzig, Germany
[3] Asklepios Clin, St Augustin, Germany
[4] Charite, Berlin, Germany
[5] Univ Hosp, Marburg, Germany
[6] Prof Hess Kinderklin, Bremen, Germany
[7] Novartis, Nurnberg, Germany
[8] Univ Hosp, Heidelberg, Germany
关键词
D O I
10.1136/annrheumdis-2020-eular.5878
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
FRI0486
引用
收藏
页码:837 / 837
页数:1
相关论文
共 50 条
  • [1] Long-Term Efficacy and Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - First Interim Analysis of the FMF-TRAPS-HIDS/MKD Subgroup of the RELIANCE Registry
    Henes, Joerg
    Blank, Norbert
    Borte, Michael
    Foeldvari, Ivan
    Horneff, Gerd
    Hufnagel, Markus
    Kallinich, Tilmann
    Kortus-Goetze, Birgit
    Schuetz, Catharina
    Weller-Heinemann, Frank
    Weber-Arden, Julia
    Kuemmerle-Deschner, Jasmin
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
  • [2] Long-term Safety of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes - Interim Analysis of the RELIANCE Registry
    Kuemmerle-Deschner, Jasmin
    Henes, Jorg
    Kortus-Goetze, Birgit
    Kallinich, Tilmann
    Oommen, Prasad T.
    Rech, Juergen
    Weller-Heinemann, Frank
    Horneff, Gerd
    Foeldvari, Ivan
    Janda, Ales
    Schuetz, Catharina
    Dressler, Frank
    Borte, Michael
    Hufnagel, Markus
    Braner, Axel
    Meier, Florian
    Fiene, Michael
    Weber-Arden, Julia
    Blank, Norbert
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 379 - 380
  • [3] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Henes, J.
    Kuemmerle-Deschner, J. B.
    Krickau, T.
    Kallinich, T.
    Dressler, F.
    Horneff, G.
    Meier, F.
    Foeldvari, I.
    Weller-Heinemann, F.
    Kortus-Goetze, B.
    Hufnagel, M.
    Rech, J.
    Oommen, P.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 29 - 30
  • [4] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH FAMILIAL MEDITERRANEAN FEVER (FMF) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Henes, J.
    Kuemmerle-Deschner, J. B.
    Kallinich, T.
    Dressler, F.
    Weller-Heinemann, F.
    Kortus-Goetze, B.
    Foeldvari, I.
    Horneff, G.
    Hufnagel, M.
    Meier, F.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 971 - 972
  • [5] LONG-TERM SAFETY OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY DISEASES - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Henes, J.
    Kortus-Goetze, B.
    Kallinich, T.
    Oommen, P.
    Rech, J.
    Krickau, T.
    Weller-Heinemann, F.
    Horneff, G.
    Janda, A.
    Foeldvari, I.
    Schuetz, C.
    Dressler, F.
    Borte, M.
    Hufnagel, M.
    Meier, F.
    Fiene, M.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1026 - 1027
  • [6] Long-Term Safety and Effectiveness of Canakinumab in Patients with MKD/HIDS: Interim Analysis of the RELIANCE Registry
    Prasad T. Oommen
    Tilmann Kallinich
    Juergen Rech
    Norbert Blank
    Julia Weber-Arden
    Jasmin B. Kuemmerle-Deschner
    Rheumatology and Therapy, 2025, 12 (1) : 137 - 155
  • [7] PHARMACOKINETICS AND PHARMACODYNAMICS OF CANAKINUMAB IN PATIENTS WITH AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES (COLCHICINE RESISTANT FMF, HIDS/MKD AND TRAPS)
    De Benedetti, F.
    Anton, J.
    Gattorno, M.
    Lachmann, H.
    Kone-Paut, I.
    Ozen, S.
    Frenkel, J.
    Simon, A.
    Zeft, A.
    Ben-Chetrit, E.
    Hoffman, H.
    Joubert, Y.
    Lheritier, K.
    Speziale, A.
    Junge, G.
    Xu, X.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 397 - 398
  • [8] LONG-TERM SAFETY OF CANAKINUMAB IN AUTOINFLAMMATORY PERIODIC FEVER SYNDROMES-48-MONTH DATA FROM THE RELIANCE REGISTRY
    Kuemmerle-Deschner, J. B.
    Henes, J.
    Kortus-Goetze, B.
    Oommen, P.
    Pankow, A.
    Kallinich, T.
    Krickau, T.
    Schuetz, C.
    Horneff, G.
    Foeldvari, I.
    Rech, J.
    Weller-Heinemann, F.
    Janda, A.
    Hufnagel, M.
    Meier, F.
    Dressler, F.
    Borte, M.
    Andreica, I.
    Wasiliew, P.
    Fiene, M.
    Windschall, D.
    Weber-Arden, J.
    Blank, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1153 - 1153
  • [9] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 1978 - 1978
  • [10] LONG-TERM EFFICACY AND SAFETY OF CANAKINUMAB IN PATIENTS WITH HIDS (HYPER-IGD SYNDROME) - INTERIM ANALYSIS OF THE RELIANCE REGISTRY
    Oommen, P.
    Kallinich, T.
    Rech, J.
    Blank, N.
    Weber-Arden, J.
    Kuemmerle-Deschner, J. B.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 1027 - 1028